These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36637174)

  • 1. Skin atrophy after skin tests with corticosteroids for the diagnosis of SARS-CoV-2 vaccine excipients hypersensitivity.
    Fabbri V; Ortolani VGR; Caron L; Bono L; Ratti CP; Iemoli E
    Eur Ann Allergy Clin Immunol; 2023 Nov; 55(6):319-322. PubMed ID: 36637174
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypersensitivity reactions to anti-SARS-CoV-2 vaccines: Basophil reactivity to excipients.
    Pignatti P; Ramirez GA; Russo M; Marraccini P; Nannipieri S; Asperti C; Torre FD; Tiri A; Gatti BM; Gurrado A; Meriggi A; Benanti G; Cilona MB; Pigatto P; Burastero SE; Dagna L; Yacoub MR
    Vaccine; 2023 Jul; 41(32):4693-4699. PubMed ID: 37349223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of New mRNA Vaccines Against COVID-19 in Severely Allergic Patients.
    Rojas-Pérez-Ezquerra P; Crespo Quirós J; Tornero Molina P; Baeza Ochoa de Ocáriz ML; Zubeldia Ortuño JM
    J Investig Allergol Clin Immunol; 2021 Apr; 31(2):180-181. PubMed ID: 33648905
    [No Abstract]   [Full Text] [Related]  

  • 4. Coronavirus disease 2019 vaccine hypersensitivity evaluated with vaccine and excipient allergy skin testing.
    Kohli-Pamnani A; Zapata K; Gibson T; Kwittken PL
    Ann Allergy Asthma Immunol; 2022 Jan; 128(1):97-98. PubMed ID: 34487840
    [No Abstract]   [Full Text] [Related]  

  • 5. Non-immunoglobulin E-mediated allergy associated with Pfizer-BioNTech coronavirus disease 2019 vaccine excipient polyethylene glycol.
    Jiang SY; Smith EM; Vo V; Akdis C; Nadeau KC
    Ann Allergy Asthma Immunol; 2021 Dec; 127(6):694-696. PubMed ID: 34547440
    [No Abstract]   [Full Text] [Related]  

  • 6. Vaccine allergy: evidence to consider for COVID-19 vaccines.
    Nilsson L; Csuth Á; Storsaeter J; Garvey LH; Jenmalm MC
    Curr Opin Allergy Clin Immunol; 2021 Aug; 21(4):401-409. PubMed ID: 34091550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PEG skin testing for COVID-19 vaccine allergy.
    Stone BD
    J Allergy Clin Immunol Pract; 2021 Apr; 9(4):1765. PubMed ID: 33838847
    [No Abstract]   [Full Text] [Related]  

  • 8. Other excipients than PEG might cause serious hypersensitivity reactions in COVID-19 vaccines.
    Borgsteede SD; Geersing TH; Tempels-Pavlica Ž
    Allergy; 2021 Jun; 76(6):1941-1942. PubMed ID: 34128559
    [No Abstract]   [Full Text] [Related]  

  • 9. Self-reported allergy to medications containing the same excipients as SARS-CoV2 vaccines: importance of skin testing with excipients.
    Biondi F; Bianchi L; Tramontana M; Marietti R; D'Arpino A; Hansel K; Stingeni L
    Ital J Dermatol Venerol; 2023 Feb; 158(1):72-73. PubMed ID: 36421077
    [No Abstract]   [Full Text] [Related]  

  • 10. COVID-19 vaccines and the role of other potential allergenic components different from PEG. A reply to: "Other excipients than PEG might cause serious hypersensitivity reactions in COVID-19 vaccines".
    Cabanillas B; Akdis CA; Novak N
    Allergy; 2021 Jun; 76(6):1943-1944. PubMed ID: 34128563
    [No Abstract]   [Full Text] [Related]  

  • 11. COVID vaccination can be performed in patients with a history of allergic reactions to the vaccines or their components: experience from a specialist clinic in South Australia.
    Tunbridge M; Perkins G; Lee M; Salehi T; Ryoo D; Kette F; Smith W; Gold M; Le TA; Yuson C; Hissaria P
    Intern Med J; 2022 Nov; 52(11):1884-1890. PubMed ID: 35848521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of lymphocyte transformation tests (LTT) in suspected severe delayed hypersensitivity reactions following COVID-19 vaccination.
    Weir C; Sung-In Jang H; Fernando SL
    Hum Vaccin Immunother; 2023 Dec; 19(1):2182527. PubMed ID: 36912718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taxanes hypersensitivity is not a risk factor for severe reactions to SARS-CoV-2 vaccines.
    Cortellini G; Raiteri A; Biagioni B; Liberati S; Lippolis D; Cortellini G; Piscaglia F
    Eur Ann Allergy Clin Immunol; 2023 Sep; 55(5):229-234. PubMed ID: 36047485
    [No Abstract]   [Full Text] [Related]  

  • 14. Mucocutaneous Adverse Reactions to COVID-19 Vaccines: Do Excipients Play a Role?
    Bianchi L; Biondi F; Hansel K; Murgia N; D'Arpino A; Tramontana M; Stingeni L
    Acta Derm Venereol; 2022 May; 102():adv00724. PubMed ID: 35535644
    [No Abstract]   [Full Text] [Related]  

  • 15. Reply to "PEG skin testing for COVID-19 allergy".
    Banerji A; Phillips E; Saff R; Wickner PG; Robinson LB; Wolfson AR; Williams P; Khan DA; Blumenthal KG
    J Allergy Clin Immunol Pract; 2021 Apr; 9(4):1765-1766. PubMed ID: 33838846
    [No Abstract]   [Full Text] [Related]  

  • 16. Pfizer-BioNTech (BNT162b2), Moderna (mRNA-1273) COVID-19 mRNA vaccines and hypersensitivity reactions.
    Haq HN; Khan H; Chaudhry H; Nimmala S; Demidovich J; Papudesi BN; Potluri SD
    J Natl Med Assoc; 2022 Dec; 114(6):601-612. PubMed ID: 36511275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of suspected and confirmed COVID-19 (SARS-CoV-2) vaccine hypersensitivity.
    Worm M; Alexiou A; Bauer A; Treudler R; Wurpts G; Dickel H; Buhl T; Müller S; Jung A; Brehler R; Fluhr J; Klimek L; Mülleneisen N; Pfützner W; Raap U; Roeseler S; Schuh S; Timmermann H; Heine G; Wedi B; Brockow K
    Allergy; 2022 Nov; 77(11):3426-3434. PubMed ID: 35722723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypersensitivity reactions to vaccines in children: from measles to SARS-CoV-2.
    Caffarelli C; Liotti L; Bianchi A; Bottau P; Caimmi S; Crisafulli G; Franceschini F; Paglialunga C; Saretta F; Mori F
    Pediatr Allergy Immunol; 2022 Jan; 33 Suppl 27(Suppl 27):58-60. PubMed ID: 35080320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Century of mRNA Vaccines: COVID-19 Vaccines and Allergy.
    Ortega Rodríguez NR; Audícana Berasategui MT; de la Hoz Caballer B; Valero Santiago A
    J Investig Allergol Clin Immunol; 2021 Feb; 31(1):89-91. PubMed ID: 33393485
    [No Abstract]   [Full Text] [Related]  

  • 20. Excipients as Potential Agents of Anaphylaxis in Vaccines: Analyzing the Formulations of Currently Authorized COVID-19 Vaccines.
    Caballero ML; Quirce S
    J Investig Allergol Clin Immunol; 2021 Feb; 31(1):92-93. PubMed ID: 33433387
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.